LGALS1 and neoplasm: Later, immunohistochemistry experiments established a functional AP-1 signature that includes Gal-1 expression in cHL and anaplastic large-cell lymphoma, suggesting a common mechanism of tumor-induced immunotolerance in these malignancies [41].